New DNA reader could crack unsolved rare disease cases
NCT ID NCT07400913
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new DNA sequencing method that reads long stretches of DNA to find hidden genetic changes causing rare diseases like albinism and intellectual disability. Researchers will analyze stored blood or DNA from 150 patients who haven't gotten a clear diagnosis yet. The goal is to see if this approach can detect methylation abnormalities (epimutations) that standard tests miss, potentially reducing diagnostic dead ends.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALBINISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Bordeaux - Hôpital Pellegrin
Bordeaux, 33076, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tiny exercise bursts might sharpen minds in intellectual disability
- Could a Self-Help guide transform parenting stress for families of kids with NDD?
- Beyond the genome: new Multi-Omics approach aims to crack the code of intellectual disability
- Brain imaging may unlock early clues to autism in tuberous sclerosis
- Can tracking a rare genetic syndrome unlock its mysteries?
- Can a simple grip test reveal mobility gaps in teens with intellectual disability?